68
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Improvement of malignant serous effusions diagnosis by quantitative analysis of molecular claudin 4 expression

, , , , , , & show all
Pages 315-324 | Received 27 Nov 2009, Accepted 27 Jan 2010, Published online: 23 Feb 2010

References

  • Backus J, Laughlin T, Wang Y, Belly R, White R, Baden J, Justus Min C, Mannie A, Tafra L, Atkins D, Verbanac KM. (2005). Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis. J Mol Diagn 7:327–36.
  • Bedrossian CW. (1998). Diagnostic problems in serous effusions. Diagn Cytopathol 19:131–7.
  • Brock MV, Hooker CM, Yung R, Guo M, Han Y, Ames SE, Chang D, Yang SC, Mason D, Sussman M, Baylin SB, Herman JG. (2005). Can we improve the cytologic examination of malignant pleural effusions using molecular analysis? Ann Thorac Surg 80:1241–7.
  • Cheung ST, Leung KL, Ip YC, Chen X, Fong DY, Ng IO, Fan ST, So S. (2005). Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. Clin Cancer Res 11:551–6.
  • Facchetti F, Lonardi S, Gentili F, Bercich L, Falchetti M, Tardanico R, Baronchelli C, Lucini L, Santin A, Murer B. (2007). Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions. Virchows Arch 451:669–80.
  • Fetsch PA, Abati A. (2001). Immunocytochemistry in effusion cytology: a contemporary review. Cancer 93:293–308.
  • Grunewald K, Haun M, Fiegl M, Urbanek M, Muller-Holzner E, Massoner A, Riha K, Propst A, Marth C, Gastl G. (2002). Mammaglobin expression in gynecologic malignancies and malignant effusions detected by nested reverse transcriptase-polymerase chain reaction. Lab Invest 82:1147–53.
  • Hewitt KJ, Agarwal R, Morin PJ. (2006). The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 6:186.
  • Hoevel T, Macek R, Mundigl O, Swisshelm K, Kubbies M. (2002). Expression and targeting of the tight junction protein CLDN1 in CLDN1-negative human breast tumor cells. J Cell Physiol 191:60–8.
  • Hou J, Renigunta A, Konrad M, Gomes AS, Schneeberger EE, Paul DL, Waldegger S, Goodenough DA. (2008). Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. J Clin Invest 118:619–28.
  • Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenshein NB, Cho KR, Riggins GJ, Morin PJ. (2000). Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 60:6281–7.
  • Johnson AH, Frierson HF, Zaika A, Powell SM, Roche J, Crowe S, Moskaluk CA, El-Rifai W. (2005). Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis. Am J Pathol 167:577–84.
  • Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S. (2003). Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22:2021–33.
  • Kominsky SL, Vali M, Korz D, Gabig TG, Weitzman SA, Argani P, Sukumar S. (2004). Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Pathol 164:1627–33.
  • Kramer F, White K, Kubbies M, Swisshelm K, Weber BH. (2000). Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer. Hum Genet 107:249–56.
  • Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, Blasig IE. (2008). Structure and function of claudins. Biochim Biophys Acta 1778:631–45.
  • Kulka J, Szasz AM, Nemeth Z, Madaras L, Schaff Z, Molnar IA, Tokes AM. (2009). Expression of tight junction protein claudin-4 in Basal-like breast carcinomas. Pathol Oncol Res 15:59–64.
  • Lee MJ, Lee HS, Kim WH, Choi Y, Yang M. (2003). Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol 16:403–10.
  • Lim TS, Vedula SR, Kausalya PJ, Hunziker W, Lim CT. (2008). Single-molecular-level study of claudin-1-mediated adhesion. Langmuir 24:490–5.
  • Long H, Crean CD, Lee WH, Cummings OW, Gabig TG. (2001). Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res 61:7878–81.
  • Michl P, Buchholz M, Rolke M, Kunsch S, Lohr M, McClane B, Tsukita S, Leder G, Adler G, Gress TM. (2001). Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 121:678–84.
  • Mohanty SK, Dey P. (2003). Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review. Postgrad Med J 79:569–74.
  • Monte SA, Ehya H, Lang WR. (1987). Positive effusion cytology as the initial presentation of malignancy. Acta Cytol 31:448–52.
  • Morin PJ. (2005). Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 65:9603–6.
  • Oki E, Maehara Y, Tokunaga E, Shibahara K, Hasuda S, Kakeji Y, Sugimachi K. (2002). Detection of disseminated cancer cells in bone marrow of gastric cancer using real time quantitative reverse transcriptase polymerase chain reaction. Cancer Lett 188:191–8.
  • Passebosc-Faure K, Li G, Lambert C, Cottier M, Gentil-Perret A, Fournel P, Perol M, Genin C. (2005). Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions. Clin Cancer Res 11:6862–7.
  • Rangel LB, Agarwal R, D’Souza T, Pizer ES, Alo PL, Lancaster WD, Gregoire L, Schwartz DR, Cho KR, Morin PJ. (2003). Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res 9:2567–75.
  • Resnick MB, Konkin T, Routhier J, Sabo E, Pricolo VE. (2005). Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 18:511–18.
  • Sanada Y, Oue N, Mitani Y, Yoshida K, Nakayama H, Yasui W. (2006). Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. J Pathol 208:633–42.
  • Sheehan GM, Kallakury BV, Sheehan CE, Fisher HA, Kaufman RP, Jr., Ross JS. (2007). Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas. Hum Pathol 38:564–9.
  • Spring K. (1998) Routes and mechanism of fluid transport by epithelia. Annu Rev Physiol 60:105–19.
  • Swisshelm K, Macek R, Kubbies M. (2005). Role of claudins in tumorigenesis. Adv Drug Deliv Rev 57:919–28.
  • Tokes AM, Kulka J, Paku S, Szik A, Paska C, Novak PK, Szilak L, Kiss A, Bogi K, Schaff Z. (2005). Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7:R296–305.
  • Tsukita S, Furuse M. (2000). Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J Cell Biol 149:13–16.
  • Winter MJ, Nagtegaal ID, van Krieken JH, Litvinov SV. (2003). The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol 163:2139–48.
  • Yu CJ, Shew JY, Liaw YS, Kuo SH, Luh KT, Yang PC. (2001). Application of mucin quantitative competitive reverse transcription polymerase chain reaction in assisting the diagnosis of malignant pleural effusion. Am J Respir Crit Care Med 164:1312–18.
  • Zhang KH, Cao F, Fu QB, Zhu JQ, Chen J, Lv NH. (2007). Detection of mRNAs of GA733 genes by RT-PCR in exfoliated cells of pleural and peritoneal effusions and its clinical values. Intern Med 46:1489–94.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.